SynOx Therapeutics UK Limited
Industrial Biotech
- Website
- https://synoxtherapeutics.com/
- Membership category
- Corporate
John Eccles House, Robert Robinson Avenue, Oxford, OX4 4GP, United Kingdom
SynOx Therapeutics UK Limited at a glance
A biopharmaceutical company developing a CSF-1R monoclonal antibody emactuzumab for TGCT, an oncological disease, to improve their life’s.
About SynOx Therapeutics UK Limited
SynOx is an innovative, science driven and patient focused biopharmaceutical company. Their mission is to develop their next generation, immunomodulating, CSF-1R targeted monoclonal antibody, called emactuzumab for patients with a rare, oncological disease, called tenosynovial giant cell tumors (TGCT) as well as for patients with other macrophage-associated diseases. TGCT is a debilitating disease that causes significant pain and disability. In early phase clinical studies, emactuzumab was well-tolerated and had promising efficacy in advanced TGCT patients.
